RUSSO RENE (CEO and President) exercised options at XILIO THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/5/2026ACC: 0001193125-26-002512
DirectorOfficer10% Owner· CEO and President
Since Oct 2021
+1.50M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.54M acquired · 44.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+44.25K
Price / share
—
Trade value
—
% of position
15.7%
1/1/2026
281.17K→325.42K
Total
Net shares
+44.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2026 | M · Option Exercise | +44.25K | — | — | 15.7% | 281.17K | 325.42K |
| Total | +44.25K | $0.00 | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
1.50M shares
Shares
+1.50M
Strike price
0.841
Held after
1.50M
Exercisable
—
12/31/2025
Restricted Stock Units
Direct
Converts to
Common Stock
44.25K shares
Shares
−44.25K
Strike price
Held after
88.50K
Exercisable
—
1/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock1.50M shares | 12/31/2025 | A · Award | +1.50M | 0.841 | — | 1.50M |
| Restricted Stock Units Direct | Common Stock44.25K shares | 1/1/2026 | M · Option Exercise | −44.25K | — | 88.50K |